Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
about
Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova.Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvementAccess to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes.Perception of quality of health delivery and health insurance subscription in Ghana.Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.Access to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesCatastrophic expenditure on medicines in Brazil.Access to medicines for chronic diseases in Brazil: a multidimensional approach.Educational strategies for the prevention of diabetes, hypertension, and obesity.Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective.Comparative health system performance in six middle-income countries: cross-sectional analysis using World Health Organization study of global ageing and health.Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis.Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya.Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study
P2860
Q30379796-CF1C583A-41E3-4BE4-8779-86D525631A36Q30383205-13896833-1DAD-4874-81CB-7CFB457EF685Q30385819-959F837A-D85A-41AB-B39D-67BABEF9E21AQ30386165-06DE9135-D0DF-4A12-AA65-1AA0FA650274Q35905686-9F71D539-AFDE-4461-9234-6DB534734AE4Q36089890-3F3FCBFF-72B4-44A6-88C2-4AFEEC889123Q36249454-6D8DA211-EB80-4ECB-AFB4-48A526FCC070Q36936076-45AC94EC-4533-4909-8C66-64E478CB9C1AQ37505797-A9C63CA5-7777-4876-9F5F-0ED251C20D50Q37505807-822FAA71-530C-4E49-961B-82F8090E63EBQ39043150-6202EE09-1941-4E52-93C7-7D940DCF157AQ46818426-59EE78AE-FD70-47D2-9200-1D4F17A12B0DQ50427555-87C33AEF-CD14-4A0E-B4FE-04C9AE4F3214Q52678845-08CBF56B-3890-4590-8DF0-E0CFFE6C2C41Q55510606-F565CFAE-0B52-45C2-86D5-324298C9805CQ58708964-66148D96-2F44-4648-AF88-4D711D48FF33
P2860
Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evidence on access to medicine ...... - and middle-income countries.
@ast
Evidence on access to medicine ...... - and middle-income countries.
@en
type
label
Evidence on access to medicine ...... - and middle-income countries.
@ast
Evidence on access to medicine ...... - and middle-income countries.
@en
prefLabel
Evidence on access to medicine ...... - and middle-income countries.
@ast
Evidence on access to medicine ...... - and middle-income countries.
@en
P2093
P2860
P356
P1476
Evidence on access to medicine ...... - and middle-income countries.
@en
P2093
Anita K Wagner
Brian Serumaga
Catherine E Vialle-Valentin
P2860
P304
P356
10.1093/HEAPOL/CZU107
P577
2014-09-24T00:00:00Z